{"id":"https://openalex.org/W4390789617","doi":"https://doi.org/10.1158/2159-8290.24988592","title":"Supplementary Methods from Xaluritamig, a STEAP1 \u00d7 CD3 XmAb 2+1 Immune Therapy for Metastatic Castration-Resistant Prostate Cancer: Results from Dose Exploration in a First-in-Human Study","display_name":"Supplementary Methods from Xaluritamig, a STEAP1 \u00d7 CD3 XmAb 2+1 Immune Therapy for Metastatic Castration-Resistant Prostate Cancer: Results from Dose Exploration in a First-in-Human Study","publication_year":2024,"publication_date":"2024-01-12","ids":{"openalex":"https://openalex.org/W4390789617","doi":"https://doi.org/10.1158/2159-8290.24988592"},"language":"en","primary_location":{"id":"doi:10.1158/2159-8290.24988592","doi":"https://doi.org/10.1158/2159-8290.24988592","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2159-8290.24988592","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/2159-8290.24988592","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063435994","display_name":"William Kevin Kelly","orcid":"https://orcid.org/0000-0003-2629-672X","observed_orcids":["https://orcid.org/0000-0003-2629-672X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William K. Kelly","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2629-672X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036310901","display_name":"Daniel Costin Danila","orcid":"https://orcid.org/0000-0002-7647-0741","observed_orcids":["https://orcid.org/0000-0002-7647-0741"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel C. Danila","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7647-0741","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036446086","display_name":"Chia\u2010Chi Lin","orcid":"https://orcid.org/0000-0002-2573-5789","observed_orcids":["https://orcid.org/0000-0002-2573-5789"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chia-Chi Lin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2573-5789","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063838757","display_name":"Jae\u2010Lyun Lee","orcid":"https://orcid.org/0000-0002-9420-7162","observed_orcids":["https://orcid.org/0000-0002-9420-7162"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jae-Lyun Lee","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9420-7162","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014625956","display_name":"Nobuaki Matsubara","orcid":"https://orcid.org/0000-0002-9203-4245","observed_orcids":["https://orcid.org/0000-0002-9203-4245"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nobuaki Matsubara","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9203-4245","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062468425","display_name":"Patrick J. Ward","orcid":"https://orcid.org/0000-0002-7800-4840","observed_orcids":["https://orcid.org/0000-0002-7800-4840"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Patrick J. Ward","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7800-4840","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038489185","display_name":"Andrew J. Armstrong","orcid":"https://orcid.org/0000-0001-7012-1754","observed_orcids":["https://orcid.org/0000-0001-7012-1754"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew J. Armstrong","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7012-1754","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090641762","display_name":"David William Pook","orcid":"https://orcid.org/0000-0002-1744-3022","observed_orcids":["https://orcid.org/0000-0002-1744-3022"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Pook","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1744-3022","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100726133","display_name":"Miso Kim","orcid":"https://orcid.org/0000-0002-4064-4199","observed_orcids":["https://orcid.org/0000-0002-4064-4199"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Miso Kim","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4064-4199","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091696839","display_name":"Tanya Barauskas Dorff","orcid":"https://orcid.org/0000-0001-5990-298X","observed_orcids":["https://orcid.org/0000-0001-5990-298X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tanya B. Dorff","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5990-298X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027035277","display_name":"Stefanie Fischer","orcid":"https://orcid.org/0000-0001-9609-3640","observed_orcids":["https://orcid.org/0000-0001-9609-3640"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stefanie Fischer","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9609-3640","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030330847","display_name":"Yung\u2010Chang Lin","orcid":"https://orcid.org/0000-0002-2084-5348","observed_orcids":["https://orcid.org/0000-0002-2084-5348"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yung-Chang Lin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2084-5348","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084855225","display_name":"Lisa Glen Horvath","orcid":"https://orcid.org/0000-0001-6842-9223","observed_orcids":["https://orcid.org/0000-0001-6842-9223"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lisa G. Horvath","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6842-9223","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016875639","display_name":"Christopher Joseph Sumey","orcid":"https://orcid.org/0000-0002-9288-2236","observed_orcids":["https://orcid.org/0000-0002-9288-2236"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christopher Sumey","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9288-2236","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030908830","display_name":"Zhao Yang","orcid":"https://orcid.org/0000-0002-1199-1052","observed_orcids":["https://orcid.org/0000-0002-1199-1052"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhao Yang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1199-1052","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004082394","display_name":"Gabor Jurida","orcid":"https://orcid.org/0009-0000-8003-1269","observed_orcids":["https://orcid.org/0009-0000-8003-1269"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gabor Jurida","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0000-8003-1269","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006727597","display_name":"Kristen M. Smith","orcid":"https://orcid.org/0000-0003-0960-0937","observed_orcids":["https://orcid.org/0000-0003-0960-0937"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kristen M. Smith","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0960-0937","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085456274","display_name":"Jamie N. Connarn","orcid":"https://orcid.org/0000-0001-7112-7357","observed_orcids":["https://orcid.org/0000-0001-7112-7357"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jamie N. Connarn","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7112-7357","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024288749","display_name":"Hweixian Leong Penny","orcid":"https://orcid.org/0009-0000-3212-0275","observed_orcids":["https://orcid.org/0009-0000-3212-0275"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hweixian L. Penny","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0000-3212-0275","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058424325","display_name":"Julia Stieglmaier","orcid":"https://orcid.org/0009-0009-7035-5855","observed_orcids":["https://orcid.org/0009-0009-7035-5855"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Julia Stieglmaier","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0009-7035-5855","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5012316179","display_name":"Leonard Joseph Appleman","orcid":"https://orcid.org/0000-0003-4951-7388","observed_orcids":["https://orcid.org/0000-0003-4951-7388"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Leonard J. Appleman","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4951-7388","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/steap1","display_name":"STEAP1","score":0.9639999866485596},{"id":"https://openalex.org/keywords/cd3","display_name":"CD3","score":0.9850000143051147},{"id":"https://openalex.org/keywords/bispecific-antibodies","display_name":"bispecific antibodies","score":0.7960000038146973},{"id":"https://openalex.org/keywords/metastatic-castration-resistant-prostate-cancer","display_name":"metastatic castration-resistant prostate cancer","score":0.9210000038146973},{"id":"https://openalex.org/keywords/clinical-trial-eligibility-criteria","display_name":"inclusion and exclusion criteria","score":0.8700000047683716},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.8880000114440918}],"concepts":[{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.8458492159843445},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6249406337738037},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5709044933319092},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4746299982070923},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.47236233949661255},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.44102615118026733},{"id":"https://openalex.org/C2779256933","wikidata":"https://www.wikidata.org/wiki/Q58929","display_name":"Castration","level":3,"score":0.41767412424087524},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.13175925612449646},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/2159-8290.24988592","doi":"https://doi.org/10.1158/2159-8290.24988592","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2159-8290.24988592","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/2159-8290.24988592.v1","doi":"https://doi.org/10.1158/2159-8290.24988592.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2159-8290.24988592.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_from_Xaluritamig_a_STEAP1_CD3_XmAb_2_1_Immune_Therapy_for_Metastatic_Castration-Resistant_Prostate_Cancer_Results_from_Dose_Exploration_in_a_First-in-Human_Study/24988592/1/files/44012834.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/24988592","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Methods_from_Xaluritamig_a_STEAP1_CD3_XmAb_2_1_Immune_Therapy_for_Metastatic_Castration-Resistant_Prostate_Cancer_Results_from_Dose_Exploration_in_a_First-in-Human_Study/24988592","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/2159-8290.24988592","doi":"https://doi.org/10.1158/2159-8290.24988592","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2159-8290.24988592","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4390789617.pdf","grobid_xml":"https://content.openalex.org/works/W4390789617.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4402560265","https://openalex.org/W4387798677","https://openalex.org/W4389280670","https://openalex.org/W4390789596","https://openalex.org/W4387810329","https://openalex.org/W7162545775","https://openalex.org/W4410809399","https://openalex.org/W7162660031","https://openalex.org/W4409690745","https://openalex.org/W4401923029"],"abstract_inverted_index":{"Supplementary":[0],"Methods:":[1],"Additional":[2],"methodology":[3],"including":[4],"full":[5,8],"inclusion":[6],"criteria,":[7,10],"exclusion":[9],"and":[11],"definition":[12],"of":[13],"dose-limiting":[14],"toxicities.":[15]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-01-13T00:00:00"}